Charles McWherter

(Dr. Charles McWherter Ph.D.)

Currently holds a position at Cymabay Therapeutics Inc

Positions
Position Company Period
Senior Vice President, Chief Scientific Officer Cymabay Therapeutics Inc None -
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Total value Details
2024-01-22 2024-01-19
PS Planned sale
3,125 -17.2%
23.68
73,988 USD 		3,125 -17.2% 23.68 73,988 USD
2024-01-22 2024-01-19
PS Planned sale
8,334 -35.7%
23.68
197,316 USD 		8,334 -35.7% 23.68 197,316 USD
2024-01-22 2024-01-19
PS Planned sale
1,916 -11.3%
23.66
45,340 USD 		1,916 -11.3% 23.66 45,340 USD
2024-01-22 2024-01-19
PS Planned sale
2,778 -15.6%
23.66
65,739 USD 		2,778 -15.6% 23.66 65,739 USD
2024-01-22 2024-01-19
PS Planned sale
2,250 -13.0%
23.67
53,262 USD 		2,250 -13.0% 23.67 53,262 USD
2023-12-18 2023-12-18
PS Planned sale
6,504 -30.2%
21.48
139,703 USD 		6,504 -30.2% 21.48 139,703 USD
2023-12-18 2023-12-18
PS Planned sale
4,828 -24.3%
21.49
103,738 USD 		4,828 -24.3% 21.49 103,738 USD
2023-10-18 2023-10-18
PS Planned sale
21,743 -59.2%
14.07
305,941 USD 		21,743 -59.2% 14.07 305,941 USD
2023-09-19 2023-09-18
PS Planned sale
21,746 -59.2%
16.22
352,733 USD 		21,746 -59.2% 16.22 352,733 USD
2023-08-18 2023-08-18
PS Planned sale
21,746 -59.2%
11.47
249,359 USD 		21,746 -59.2% 11.47 249,359 USD
2023-07-19 2023-07-18
PS Planned sale
21,749 -59.2%
11.43
248,519 USD 		21,749 -59.2% 11.43 248,519 USD
2023-06-21 2023-06-20
PS Planned sale
21,749 -59.2%
8.16
177,383 USD 		21,749 -59.2% 8.16 177,383 USD
2023-05-19 2023-05-18
PS Planned sale
21,749 -59.2%
9.08
197,387 USD 		21,749 -59.2% 9.08 197,387 USD